Chinese doctor Li Xiushan checks the eyes of a boy at the Ethio-China Friendship Hospital, located in Akaki at the outskirts of Ethiopia's capital Addis Ababa, Ethiopia, Aug. 17, 2018. (Xinhua/Lyu Shuai)
ADDIS ABABA, May 30 (Xinhua) -- Ethiopia is seeking to attract more Foreign Direct Investment (FDI) from Chinese firms engaged in the pharmaceutical sector, according to an Ethiopian official.
Dewano Kedir, Head of economic affairs desk at Ethiopia Ministry of Foreign Affairs (MoFA), said Ethiopia is willing to help Chinese firms to engage either in joint venture or full-scale investment in pharmaceutical sector in the country, reported local media outlet Ethiopianreporter.com.
Kedir pledged to assist prospective Chinese firms to overcome any hurdles they may encounter during their activities to invest in the Ethiopian pharmaceutical sector.
Kedir was speaking on Wednesday in the Ethiopian capital Addis Ababa while holding discussions with around 40 companies that came from the central Chinese province of Henan.
"Ethiopia's 100 million strong population needs to get a reliable supply of medical products. Chinese firms can help Ethiopia's fledgling pharmaceutical sector by investing in the sector as well as contributing generally to Ethiopia's export-driven industrialization program" further said Kedir.
Doctor Wang Zhijing (L), member of a Chinese medical team, talks with an Ethiopian doctor at the Tirunesh Beijing General Hospital in southern outskirts of Addis Ababa, capital of Ethiopia, Aug. 4, 2017. (Xinhua/Michael Tewelde)
On Monday, the Ethiopia Investment Commission (EIC) disclosed that Ethiopia's Chinese-built Kilinto Industrial Park (KIP) has boosted the country's ambition to lure experienced international pharmaceutical companies across the globe.
EIC revealed it has signed investment agreements with 10 international companies that have "shown great interest" to set up their industrial plants inside the premises of KIP.
According to the Ethiopian government, the Kilinto Industrial Park is on the verge of completion, and once completed it will host more than 1,000 pharmaceutical companies.
